Publications

5539 Results

Time from treatment to subsequent diagnosis of brain metastases in Stage III non-small cell lung cancer (NSCLC): a retrospective review by the Southwest Oncology Group (SWOG)

Authors
LE Gaspar;K Chansky;KS Albain;E Vallieres;V Rusch;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:636(#2558)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509

Evaluation of ZD1839 for advanced transitional cell carcinoma (TCC) of the urothelium: a Southwest Oncology Group trial

Authors
D Petrylak;JR Faulkner;PJ Van Veldhuizen;M Mansukhani;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 22:403(#1619)
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
S0031

Phase III comparison of tamoxifen versus tamoxifen with ovarian ablation in premenopausal women with axillary node-negative receptor-positive breast cancer < 3 cm

Authors
NJ Robert;M Wang;D Cella;S Martino;D Tripathy;J Ingle;LJ Solin;WC Wood
Journal / Conference
Proc of the American Society of Clinical Oncology 22:5(#16)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9347 (INT-0142) (E3193)

Phase III study of conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in patients with stage II and III breast cancer at high risk of recurrence (INT 0121)

Authors
M Tallman;R Gray;N Robert;C Osborne;W Vaughan;W Gradishar;T Pisansky;J Fetting;E Paietta;H Lazarus
Journal / Conference
Proc of the American Society of Clinical Oncology 22:6(#19)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-9061 (EST-2190) (INT-0121)

LVEF assessment of adjuvant doxorubicin/cyclophosphamide (AC) vs doxorubicin/docetaxel (AT) in early stage breast cancer: cardiac safety results of ECOG 2197.

Authors
LJ Goldstein;A O'Neill;JA Sparano;EA Perez;LN Shulman;S Martino;AC Wolff;NE Davidson
Journal / Conference
Proc of the American Society of Clinical Oncology 22:19(#73)
Year
2003
Research Committee(s)
Breast
Study Number(s)
E2197

Chemohormonal therapy in premenopausal node-positive, receptor-positive breast cancer: an Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT-0101).

Authors
NE Davidson;A O'Neill;A Vukov;CK Osborne;S Martino;D White;M Abeloff
Journal / Conference
Proc of the American Society of Clinical Oncology 22:5(#15)
Year
2003
Research Committee(s)
Breast
Study Number(s)
SWOG-8851 (INT-0101) (EST-5188)

EGFR, HER2 and ERB-B pathway activation in bronchioloalveolar carcinoma (BAC): analysis of SWOG 9417 and lung spore tissue samples.

Authors
WA Franklin;PH Gumerlock;J Crowley;K Chansky;HJ West;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:620(#2493)
Year
2003
Research Committee(s)
Lung
Study Number(s)
S9714

Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcomas (STS).

Authors
GV Burton;C Rankin;LE Flaherty;EC Borden;GM Mills;K Antman
Journal / Conference
Proc of the American Society of Clinical Oncology 22:820(#3297)
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
S9802

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an Intergroup trial

Authors
DB Duggan;GR Petroni;JL Johnson;JH Glick;RI Fisher;JM Connors;GP Canellos;BA Peterson
Journal / Conference
Journal of Clinical Oncology 21(4):607-614
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8952 (INT-0111) (CALGB-8952) (EST-5489)

Application of imaging approaches to the monitoring of immune-based therapies for breast cancer

Authors
B Almond;RM Ahlquist;DA Mankoff;ML Disis;KL Knutson
Journal / Conference
Proc of the American Association for Cancer Research 44:#3807
Year
2003